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ABSTRACT: The prototypic long pentraxin PTX3 is a unique fluid-phase pattern recognition receptor that
plays a nonredundant role in innate immunity and female fertility. The PTX3 C-terminal domain is required
for C1q recognition and complement activation and contains a single N-glycosylation site on Asn 220. In
the present study, we characterized the structure of the human PTX3 glycosidic moiety and investigated
its relevance in C1q interaction and activation of the complement classical pathway. By specific endo
and exoglycosidases digestion and direct mass spectrometric analysis, we found that both recombinant
and naturally occurring PTX3 were N-linked to fucosylated and sialylated complex-type sugars.
Interestingly, glycans showed heterogeneity mainly in the relative amount of bi, tri, and tetrantennary
structures depending on the cell type and inflammatory stimulus. Enzymatic removal of sialic acid or the
entire glycosidic moiety equally enhanced PTX3 binding to C1q compared to that in the native protein,
thus indicating that glycosylation substantially contributes to modulate PTX3/C1q interaction and that
sialic acid is the main determinant of this contribution. BIAcore kinetic measurements returned decreasing
Koff values as sugars were removed, pointing to a stabilization of the PTX3/C1q complex. No major
rearrangement of PTX3 quaternary structure was observed after desialylation or deglycosylation as
established by size exclusion chromatography. Consistent with C1q binding, PTX3 desialylation enhanced
the activation of the classical complement pathway, as assessed by C4 and C3 deposition. In conclusion,
our results provided evidence of an involvement of the PTX3 sugar moiety in C1q recognition and
complement activation.
The long pentraxin PTX3 is an acute-phase glycoprotein
of 45 kDa with glycosylation accounting for about 10% of
its molecular weight (1). The protein is secreted by natural
immunity cells and by several somatic cell types in response
to either the inflammatory cytokines interleukin-1 â (IL-1â)1
and tumor necrosis factor R (TNFR) or the selected pathogen-
associated molecular patterns (PAMPs) (2-4).
Like other members of the pentraxin family, PTX3 has a
complex oligomeric structure with protomers linked to each
other by disulfide bonds (5). PTX3 shares functional
similarities with both short pentraxins CRP (C-reactive
protein) and SAP (serum amyloid P component). It is
involved in host defense against pathogen infection, in the
regulation of the scavenger activity of macrophages and
dendritic cells (DC), and in modulation of complement
activity by binding to C1q (6-8). More recently, other
functions have been characterized regarding the involvement
of PTX3 in matrix deposition by cumulus cells (9) and the
inhibition of angiogenesis by PTX3 interaction to fibroblast
growth factor-2 (FGF-2) (10).
To date, little is known about the type of oligosaccharides
linked to PTX3, and no data are available on the functional
role of PTX3 glycosylation. Oligosaccharides may affect
protein activity in various ways: they can mask a large region
of the molecule to ligand recognition, participate in protein
folding, and define binding sites on the protein surface (11-
15). Inflammation can induce significant changes in the
oligosaccharides of acute phase proteins (16, 17), and the
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variation in protein glycosylation is a diagnostic indicator
of a number of diseases (18, 19).
Pentraxins are a family of proteins described to be variably
glycosylated among species (20). It has recently been found
that human SAP, known to be homogeneously glycosylated
(21), can show microheterogeneity at the level of its complex
biantennary oligosaccharides because of the loss of one or
both terminal sialic acid residues (22). It is noteworthy that
following desialylation SAP oligosaccharide chains exhibit
a new orientation that determines conformational changes
in protein tertiary and quaternary structures (23, 24). Human
CRP has been traditionally described as an unglycosylated
protein (25). Surprisingly, it has been recently reported that
different pathological conditions induce a novel glycosylation
of the protein (26) and that differentially glycosylated CRPs
exhibit variable binding to known ligands (27). These data
indicate that the glycosylation status of pentraxins might
contribute to the definition of their structural and biological
properties and emphasizes the importance of further explora-
tions of the role exerted by oligosaccharides in other
members of the family.
We investigated the structure and functional role of the
human PTX3 glycosidic moiety using proteins from three
different sources: the recombinant PTX3 produced in a
chinese hamster ovary (CHO) cell line, the protein from
human peripheral blood monocyte-derived DC stimulated
with lipopolysaccharide (LPS), and that from human fibro-
sarcoma cells 8387 stimulated with TNFR. We found that
PTX3 was mainly N-linked to fucosylated and sialylated
biantennary complex-type sugars. PTX3 glycans showed
heterogeneity in the relative amount of bi, tri, and tetran-
tennary structures depending on cell type and inflammatory
stimulus. Enzymatic deglycosylation or desialylation equally
enhanced (2-3-fold) PTX3 binding to C1q compared to that
in the unmodified protein. Consistent to C1q binding, the
selective removal of sialic acid increased the PTX3-depend-
ent activation of the classical complement pathway 2-fold,
as assessed by C3 and C4 deposition. Thus, we provide
evidence that PTX3 glycosylation status is directly implicated
in the protein biological function and tunes the action of this
prototypic long pentraxin.
MATERIALS AND METHODS
Purified Proteins. Recombinant human PTX3 (PTX3r) was
purified from CHO cells stably and constitutively expressing
the protein as described (1). Naturally occurring protein was
purified by immunoaffinity from human fibrosarcoma cells
8387 exposed to TNF-R (20 ng/mL) for 24 h (PTX38387)
and from human peripheral blood monocyte-derived DC
stimulated with 100 ng/mL of LPS for 24 h (PTX3DC) as
previously described (28, 4). In both cases, PTX3 was
purified using the monoclonal antibody MNB4 cross-linked
to a Protein G Sepharose column according to the manu-
facturer’s instructions. C1q from human serum was available
from Calbiochem, La Jolla, CA.
Enzymes and Chemicals. PNGase F and endoglycosidases
F1, F2, and F3 (from Chryseobacterium meningoseptum),
R-(2f3,6,8,9)-neuraminidase (from Arthrobacter ureafa-
ciens), â-(1f4)-galactosidase and â-N-acetylglucosaminidase
(from Streptococcus pneumoniae), proteomics grade trypsin
(from porcine pancreas), bovine serum albumin (BSA),
phosphate buffered saline (PBS) tablets, Triton X-100, Tween
20, 3,3′,5,5′-tetramethylbenzidine (TMB), dithiothreitol (DTT),
and iodoacetamide were purchased from Sigma Aldrich, St.
Louis, MO. LPS (Escherichia coli 055:B5) was from Difco,
Detroit, MI, and TNFR was from BASF/Knoll, Ludwig-
shafen, Germany. Electrophoresis reagents were obtained
from Bio-Rad, Hercules, CA. The 96-well microtiter plates
were from Nunc, Roskilde, Denmark. The Protein G
Sepharose 4 fast flow was purchased from Amersham
Pharmacia Biotech, Uppsala, Sweden. Prepacked C18 Sep-
Pak cartridges were from Waters, Milford, MA. All other
reagents and solvents were from Carlo Erba, Rodano, Italy
and of the highest purity available.
Antibodies. Biotin-labeled rabbit anti-human PTX3 poly-
clonal antibody RPTX3pb and rat anti-human PTX3 mono-
clonal antibody MNB4 were obtained from “Mario Negri”
Pharmacological Research Institute, Milan, Italy. Horseradish
peroxidase (HRP)-conjugated streptavidin was purchased
from Amersham Pharmacia Biotech. Goat anti-human C1q
polyclonal antibody was from Calbiochem. Rabbit anti-goat
IgG conjugated to HRP was from Sigma Aldrich. Mouse
anti-human C1q monoclonal antibody mAb85 and Dig-
conjugated mouse anti-human C4 monoclonal antibody C4-
4a and anti-human C3 monoclonal antibody RFK22 were
obtained from Leiden University Medical Center, Leiden,
The Netherlands. HRP-conjugated F(ab′)2 from goat anti-
Dig polyclonal antibody was purchased from Roche, Man-
nheim, Germany.
Gel Electrophoresis. Polyacrylamide gels (8.5%), along
with sodium dodecyl sulfate (SDS), were put through a
Laemmli (29) discontinuous buffer system. The gels were
stained with Coomassie Brilliant Blue or silver nitrate (30).
PNGase F Digestion. PNGaseF digestion was carried out
on PTX3r, PTX38387, and PTX3DC. Protein samples (5 íg)
in PBS (10 mM phosphate buffer, 2.7 mM potassium
chloride, 137 mM sodium chloride at pH 7.4) were first made
0.1% in SDS and 0.05 M in â-mercaptoethanol, then heated
at 95 °C for 5 min. After the addition of Triton X-100 to a
final concentration of 1%, the protein was incubated with 5
mU of PNGase F in a volume of 15 íL. Following 3 h of
incubation at 37 °C, the samples were analyzed by SDS-
PAGE.
Endo and Exoglycosidase Analysis. Endoglycosidase reac-
tions were performed with Chryseobacterium endoglycosi-
dases F1, F2, and F3. PTX3r, PTX38387, and PTX3DC were
first dialyzed against 50 mM sodium phosphate at pH 5.5
and then incubated in separate reactions with 1 mU of
endoglycosidase F1, F2, or F3 per íg of protein. Hydrolysis
proceeded for 16 h at 37 °C, and then the products were
analyzed by SDS-PAGE. PTX3r samples treated with
endoglycosidase F3 (endo F3-PTX3r) were purified by size
exclusion chromatography. Eluted proteins were quantitated
by Lowry (31) and assayed for C1q binding activity.
Exoglycosidase digestions were carried out as outlined for
PNGase F deglycosylation, except for enzyme/substrate
ratios. R-(2f3,6,8,9)-Neuraminidase (1 mU), â-(1f4)-
galactosidase (1 mU), and â-N-acetylglucosaminidase (10
mU) per íg of protein were used singularly or differently
combined. In another set of experiments, PTX3r, PTX38387,
and PTX3DC samples were desialylated under nondenaturing
conditions (asialo-PTX3). Reactions were performed in PBS
for 16 h at 37 °C, using 2 mU of R-(2f3,6,8,9)-neuramini-
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dase per íg of protein. Following SDS-PAGE analysis, the
reaction products were purified and assayed for C1q binding
activity as described above for endo F3-PTX3r.
Isolation of N-Linked Oligosaccharides. PTX3r (300 íg)
was reduced and alkylated as previously described (32).
Aliquots of the reduced and carboxymethylated protein were
digested overnight with trypsin in 50 mM ammonium
bicarbonate (pH 8.5) at 37 °C using a 1:50 enzyme/substrate
ratio (w/w). Samples were then diluted with water and
lyophilized. Deglycosylation of the peptide mixture was
performed overnight by treatment with 100 mU of PNGase
F per 300 íg of protein in 50 mM ammonium bicarbonate
(pH 8.5) at 37 °C. The N-linked oligosaccharides were
separated from the peptides by reverse-phase chromatography
on prepacked C18 Sep-Pak cartridges (33).
Methanolysis and Chemical DeriVatization for GC-MS
Analysis. PTX3r (200 íg) was dissolved in 500 íL of 1 M
methanolic-HCl at 80 °C for 16 h. The re-N-acetylation of
the monosaccharide mixture was performed by adding 500
íL of methanol, 10 íL of pyridine, and 50 íL of acetic
anhydride at room temperature for 15 min. Sugars were
finally trimethylsilylated in 200 íL of N,O-bis-(trimethyl-
silyl)-acetamide (TMSA) at 70 °C for 15 min. The sample
was dried under nitrogen, dissolved in 50 íL of hexane, and
centrifuged to remove any excess solid reagent. The hexane
supernatant (1/60) was used for GC-MS analysis.
MALDI-MS Analysis. Both positive and negative MALDI-
MS analyses and MALDI-PSD experiments were carried out
on a Voyager DE STR Pro instrument operating in reflectron
mode (Applied Biosystems, Framingham, MA). The MALDI
matrixes were prepared by dissolving 10 mg of 2,5-
dihydroxybenzoic acid (2,5-DHB) in 1 mL of methanol or
10 mg of R-cyano-4-hydroxycinnamic acid (HCCA) in 1 mL
of acetonitrile/0.2% trifluoroacetic acid (TFA) (70:30 v/v).
Typically, 1 íL of the matrix was applied to the metallic
sample plate, and 1 íL of analyte was then added. Accelera-
tion and reflector voltages were set up as follows: target
voltage at 20 kV, first grid at 66% of target voltage, and
delayed extraction at 200 ns. The PSD fragment spectra were
acquired after pseudomolecular cation selection using a time
ion selector. Fragment ions were refocused by a 20%
stepwise reduction of reflector voltage. The individual
segments were then stitched together using Applied Biosys-
tems software. Raw data were analyzed using computer
software provided by the manufacturers and are reported as
monoisotopic masses.
GC-MS Analysis. GC-MS analyses were performed on a
Hewlett-Packard 5890 instrument under the following condi-
tions: ZB-5 capillary column (Phenomenex, 30 m  0.25
mm i.d., flow rate 0.8 mL/min, He as carrier gas). The
injection temperature was 250 °C. For sugar analyses, the
oven temperature was increased from 25 to 90 °C in 1 min
and kept at 90 °C for 1 min before increasing to 140 °C at
25 °C/min, to 200 °C at 5 °C/min, and finally to 300 °C at
10 °C/min. Electron ionization (EI) mass spectra were
recorded by continuous quadrupole scanning at 70 eV
ionization energy.
C1q Binding Assays. PTX3r, PTX38387, PTX3DC, and the
corresponding desialylated and deglycosylated proteins were
assayed for their C1q binding activity in direct binding
assays. The 96-well plates were coated overnight at 4 °C
with 50 ng/well of C1q in PBS. All reaction volumes were
100 íL, and the plates were washed after each step with
PBS containing 0.1% v/v Triton X-100. The wells were
blocked with PBS containing 0.1% v/v Triton X-100 and
1% w/v BSA for 2 h at room temperature. Protein samples
were diluted in blocking solution and added to the wells.
Binding was then carried out for 1 h at room temperature.
After extensive washing, the plates were incubated with the
RPTX3pb polyclonal antibody (1:10000 in PBS, 0.1% Triton
X-100, 1% BSA; 1 h at room temperature) followed by HRP-
labeled streptavidin (1:4000 in PBS, 0.1% Triton X-100, 1%
BSA; 1 h at room temperature). Finally, TMB was added as
a chromogen substrate for HRP, and absorbance values were
read at 450 nm. The binding of PTX3r to C1q was also
assessed by inhibition experiments. The plates were coated
overnight at 4 °C with PTX3r or asialo-PTX3r (100 íL/well
of a 1 íg/mL solution in 50 mM sodium carbonate at pH
9.6). All reaction volumes were 100 íL, and the plates were
washed after each step with PBS containing 0.05% v/v
Tween 20. The wells were blocked with PBS containing
0.05% v/v Tween 20 and 1% w/v BSA for 1 h at 37 °C; in
a separate 96-well cell culture plate, the mixtures of a fixed
amount of C1q (5 íg/mL in blocking solution) and serial
dilutions of PTX3r or asialo-PTX3r (from 5 íg/mL to 80
ng/mL in blocking solution) were preincubated for 1 h at 37
°C. Then mixtures were added to either PTX3r- or asialo-
PTX3r-coated wells, incubation was prolonged for another
hour at 37 °C. Following extensive washing, bound C1q was
revealed using the anti-C1q polyclonal antibody (1:5000 in
blocking solution) followed by HRP-labeled secondary
antibody (1:4000 in blocking solution). Binding was detected
as indicated above. Raw data were analyzed by the SigmaPlot
statistics package (version 7.101, Systat Software, Point
Richmond, CA), and the results were expressed as both
inhibition percentages (relative to free C1q) and IC50 values
(protein concentration that inhibits 50% C1q binding). endo
F3-PTX3r was assayed in a similar experimental setting.
Complement ActiVation. Activation of complement via
PTX3r and asialo-PTX3r was assessed as described (8).
Briefly, microtiter wells were coated with PTX3r, asialo-
PTX3r, purified human IgM, or BSA and blocked by BSA.
Subsequently, the plates were incubated with NHS as a
complement source, diluted in GVB+/+ (1.8 mM sodium 5,5-
diethylbarbital, 0.2 mM 5,5-diethylbarbituric, 145 mM NaCl,
2 mM CaCl2, 5 mM MgCl2, 0.05% Tween 20, and 0.1%
gelatin) and incubated for 1 h at 37 °C. In some experiments,
NHS was diluted in GVB+/+ containing 5 íg/mL of mAb85
in a calcium-free buffer (GVB+/-/MgEGTA: 1.8 mM
sodium 5,5-diethylbarbital, 0.2 mM 5,5-diethylbarbituric, 145
mM NaCl, 5 mM MgCl2, 10 mM EGTA, 0.05% Tween 20,
and 0.1% gelatin) or in a calcium- and magnesium-free buffer
(GVB-/-/EDTA: 1.8 mM sodium 5,5-diethylbarbital, 0.2
mM 5,5-diethylbarbituric, 145 mM NaCl, 10 mM EDTA,
0.05% Tween 20, and 0.1% gelatine). The deposition of C3
and C4 was detected by Dig-conjugated RFK22 and C4-4a,
respectively. To determine the effect of desialylation on
PTX3 complement activation, a C1q-dependent haemolytic
assay was performed in the presence of increasing concentra-
tions of PTX3r and asialo-PTX3r as described earlier (34).
Size Exclusion Chromatography. PTX3, asialo-PTX3, or
endo F3-PTX3 was purified by size exclusion chromatog-
raphy. Protein samples in PBS were applied to a Superose 6
column (Amersham Pharmacia Biotech) calibrated with
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molecular weight standards and eluted with PBS at a flow
rate of 0.4 mL/min. Elution was monitored by UV detection
at 280 nm.
ELISA. PTX3, asialo-PTX3, and endo F3-PTX3 were
dosed with a sandwich ELISA on the basis of the monoclonal
antibody MNB4 and the rabbit polyclonal antibody RPTX3pb
(4).
Biosensor Analysis. The interaction with C1q of PTX3r,
asialo-PTX3r, or endo F3-PTX3r was also analyzed through
a BIAcore system (biomolecular interaction analysis; BIA-
core AB, Uppsala, Sweden). C1q was immobilized on a CM5
sensor chip (BIAcore AB) using the amine coupling kit
(BIAcore AB). A volume of 35 íL of the ligand (50 íg/mL
of C1q in 10 mM MES at pH 6.1) was immobilized with a
continuous flow of HBS (10 mM HEPES, 150 mM NaCl,
3.4 mM EDTA, 0.05% BIAcore surfactant P20 at pH 7.4)
at 5 íL/min. Each binding assay was performed with a
constant flow rate (25 íL/min) of HBS (pH 7.4) at 25 °C.
The analytes were injected over the ligand surface in HBS,
and the surface was then regenerated by injection of 25 íL
of 5 mM NaOH. Kinetic analyses were performed with serial
dilutions of the analytes in HBS to concentrations ranging
from 20 to 200 nM. Each sample was injected and allowed
a total contact time of 4 min with the ligand surface.
Homology Modeling. The primary sequence of the human
PTX3 C-terminus domain shares 28% identity with the
overall sequence of human CRP. A 3D model of the human
PTX3 C-terminus domain (aa 178-381) was thus built using
the crystallographic structure of human CRP as a template
(35) (pdb code: 1B09). Multialignment was performed using
ClustalW (http://www2.ebi.ac.uk/clustalw/) and then refined
by hand to localize insertions and deletions out of conserved
secondary structures. SwissPDB software (http://www.ex-
pasy.org/spdbv/) was utilized to obtain a preliminary 3D
model. The conserved disulfide bond, between Cys210 and
Cys271, was imposed as the constraint. Structure optimiza-
tion was performed by molecular dynamics (force field
OPLS-AA in water, 200 ps at 300 K, using a 300 kJ mol-1
Å-2 constraint on â-strand and R-helical motives), and 20
structures were extracted and minimized using SD and
TNCG algorithms up to a convergence criterion of 5  10-3
kJ mol-1 Å-1. The best solution in terms of the percentage
of amino acids in the most favorite and allowed regions was
chosen using the utility Procheck (http://www.biochem.
ucl.ac.uk/roman/procheck/procheck.html).
Conformational Analysis of Biantennary Oligosaccharides.
A core-monofucosylated and disialylated biantennary oli-
gosaccharide was built using the scheme reported in Figure
8A and linked to Asn220. Psi and Phi values for each
disaccharide unit were extracted from the Glytorsion database
(http://www.glycosciences.de/tools/glytorsion/). We per-
formed a dihedral angle driving conformational analysis,
rotating every 30° the torsion angles chi1 and chi2 on Asn220
and phi on the first GlcNAc of the oligosaccharide chain.
The four most diverse conformations, in contact with the
protein, were then submitted to a Metropolis Monte Carlo/
Stochastic Dynamics procedure (MC/SD) (force field OPLS-
AA in water, 100 dynamics time step ) 100 fs every Monte
Carlo trial, up to 1 ns). A combination of 2-4 torsion angles,
phi and psi of each disaccharide, were allowed to randomly
rotate every 30°. This protocol could guarantee an acceptance
ratio >10%. All side chains of the amino acids within a
distance of 28 Å from the first mannose were kept free. The
same calculations were performed using as input a core-
monofucosylated desialylated biantennary oligosaccharide.
One hundred conformations for each initial input were
retained, minimized, and then clustered to choose the most
representative ones. All calculations were performed using
the software Macromodel (version 8.6, Schrodinger L. L.
C., Portland, OR).
RESULTS
Endo and Exoglycosidase Analyses. It was reported in a
previous investigation that PTX3 primary sequence shows
a single potential N-glycosylation site at amino acid position
220 (1). To better characterize the PTX3 glycosylation status,
the protein was treated with substrate-specific endo and
exoglycosidases (Table 1), and the extent of deglycosylation
was monitored as an increase in electrophoretic mobility in
SDS-PAGE.
PNGaseF, an enzyme that cleaves Asn-linked high man-
nose as well as hybrid and complex oligosaccharides (36),
reduced the apparent molecular weight of PTX3r (Figure 1A)
from 45 to 40 kDa, thus confirming the presence of N-linked
glycans.
FIGURE 1: SDS-PAGE analysis of endo and exoglycosidase-treated
PTX3r. (A) Purified PTX3r was incubated with PNGase F under
denaturing conditions and then analyzed on a 8.5% SDS polyacryl-
amide gel (lane P). The untreated protein is shown in lane C. (B)
PTX3r samples were subjected to hydrolysis with endoglycosidase
F1 (lane 1), endoglycosidase F2 (lane 2), or endoglycosidase F3
(lane 3) under nondenaturing conditions in 50 mM sodium
phosphate at pH 5.5. The electrophoretic mobility produced by the
reaction products were compared to that of the untreated protein
(lane C) and the PNGase F deglycosylated PTX3r (lane P), as in
A. (C) Following SDS denaturation and â-mercaptoethanol reduc-
tion, PTX3r was incubated with R-(2f3,6,8,9)-neuraminidase (lane
1), â-(1f4)-galactosidase (lane 2), or â-N-acetylglucosaminidase
(lane 3). Enzymes were also combined two by two (lane 4,
R-(2f3,6,8,9)-neuraminidase and â-(1f4)-galactosidase; lane 5,
R-(2f3,6,8,9)-neuraminidase and â-N-acetylglucosaminidase; lane
6, â-(1f4)-galactosidase and â-N-acetylglucosaminidase), or all
three were used (lane 7). The extent of deglycosylation was
monitored in comparison to that of the untreated (lane C) and
PNGase F deglycosylated proteins (lane P), as in B.
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To establish the general type of PTX3r sugars, we
evaluated their reactivity toward the Chryseobacterium
endoglycosidases F1, F2, and F3. These enzymes cleave the
glycosidic bond between the two GlcNAc residues in the
diacetylchitobiose core with type-dependent specificity (Table
1). Because endoglycosidases F1, F2, and F3 are less
sensitive to protein conformation than PNGase F (36), the
reactions were performed in nondenaturing conditions. The
resistance of PTX3r to endoglycosidase F1 deglycosylation
(Figure 1B, lane 1) indicates that neither high mannose nor
hybrid oligosaccharides are linked to the protein. As a
positive control of enzyme activity, carboxypeptidase Y, a
glycoprotein carrying only high mannose N-linked glycans
(37), was effectively deglycosylated by endoglycosidase F1
(data not shown). Treatment of PTX3r with both endogly-
cosidases F2 and F3 (Figure 1B, lanes 2 and 3, respectively)
produced a reduction of the apparent molecular weight
comparable to that obtained after PNGase F deglycosylation,
thus revealing the presence of complex-type oligosaccharides.
Neither the F2 nor the F3 endoglycosidase completely
removed glycosylation from PTX3r because a small amount
of protein remained uncleaved at the molecular weight of
45 kDa. The specificity of endoglycosidase F2 for complex
biantennary structures indicates that the nondeglycosylated
fraction of PTX3r is presumably conjugated to triantennary
and tetrantennary oligosaccharides. No tetrantennary struc-
tures can be recognized from any of the endoglycosidases
used, which can explain the persistence of a minor amount
of glycosylated PTX3r, even after the endoglycosidase F3
treatment. Taken together, these results indicate that the
protein is conjugated to complex-type sugars with a preva-
lence of biantennary and a lower amount of tri and tetran-
tennary structures.
To confirm the complex type of PTX3r sugars and to
further characterize the structural features of their antennae,
we analyzed, in SDS-PAGE, the electrophoretic mobility
of PTX3r subjected to treatment with specific exoglycosi-
FIGURE 2: Monosaccharide composition and site occupancy analysis
of PTX3r sugars. (A) PTX3r oligosaccharides were reduced to
constituent monosaccharides by methanolysis. Trimethylsilyl-
derivatives were separated on a GC column and identified by
characteristic fragmentation patterns in electron ionisation (EI) mass
spectrometry. The corresponding total ion current (TIC) chromato-
gram showed the appearance of peaks representative of the specified
residues. Contaminants are referred to with asterisks. (B) PTX3r
was reduced and alkylated, then subjected to trypsin digestion; the
resulting peptide mixture was deglycosylated by PNGase F treat-
ment and directly analyzed by MALDI-MS operating in positive
ion mode. The mass signals recorded in the spectrum were assigned
to the corresponding peptides within the PTX3 sequence (in
brackets) on the basis of their mass value and trypsin specificity.
Only the portion of the spectrum spanning the molecular mass of
the peptide 215-230, containing the unique N-glycosylation site,
is shown. An expanded view showing the isotopic pattern of the
mass signal at m/z 1771.94 is shown in the insert.
FIGURE 3: PTX3r sugar profiling and PSD fragmentation by
MALDI-MS. Oligosaccharides were released from PTX3r polypep-
tide backbone by PNGase F digestion and directly analyzed by
MALDI-MS both in positive (A) and negative (B) ion mode.
Corresponding sodiated pseudomolecular ions were recorded in the
positive MALDI-MS spectrum, whereas pseudomolecular anions
were observed in the negative spectrum. Glycoform structures
inferred by MS data are shown; satellite peaks in B are attributed
to Na+ (*) or K+ (°) adducts. (C) The MNa+ ion at m/z 1808.64
was selected as a precursor ion and submitted to PSD fragmentation.
Y and B ions as well as fragments originated by double cleavages
are indicated. Symbols are 4, fucose; 0, N-acetylglucosamine; b,
mannose; O, galactose; ], N-acetylneuraminic acid.
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dases (Table 1). The incubation of PTX3r with R-(2f3,6,8,9)-
neuraminidase produced a slight but appreciable increase in
protein electrophoretic mobility (Figure 1C, lanes 1), thus
indicating terminal residues of sialic acid. The treatment of
PTX3r with either â-(1f4)-galactosidase or â-N-acetylglu-
cosaminidase let the protein’s apparent molecular weight
unmodified (Figure 1C, lanes 2 and 3, respectively). Incuba-
tion with R-(2f3,6,8,9)-neuraminidase and â-N-acetylglu-
cosaminidase (Figure 1C, lane 5) produced an increase in
the PTX3r electrophoretic mobility similar to that observed
after treatment with R-(2f3,6,8,9)-neuraminidase, confirm-
ing the occurrence of terminal NeuNAc residues. Moreover,
a mixture of â-(1f4)-galactosidase and â-N-acetylglu-
cosaminidase was unable to modify the apparent molecular
weight of PTX3r (Figure 1C, lanes 6), indicating that Gal
and GlcNAc residues are protected from enzyme hydrolysis
by NeuNAc monosaccharides at the nonreducing termini of
the antennae. The incubation of PTX3r with a combination
of R-(2f3,6,8,9)-neuraminidase and â-(1f4)-galactosidase
or with all of the three exoglycosidases (Figure 1C, lanes 4
and 7, respectively) produced a greater reduction of the
protein molecular weight than that observed after treatment
of PTX3r with R-(2f3,6,8,9)-neuraminidase alone. These
results are consistent with the general motif NeuNAc-Gal-
GlcNAc, which is representative of complex-type sugar
antennae and points out the presence of NeuNAc residues
as capping sugars.
Mass Spectrometry. The carbohydrate moiety of PTX3r
was submitted to detailed structural characterization by
exploiting different mass spectrometric methodologies.
The monosaccharide composition of PTX3r glycans was
determined by GC-MS analysis. The total ion current (TIC)
profile (Figure 2A) showed the occurrence of Fuc, Man, Gal
as well as GlcNAC, and NeuNAc residues. These data are
consistent with the presence of complex-type glycans
indicated by the endo and exoglycosidase analyses described
above. Moreover, the appearance of Fuc signals suggests that
PTX3r oligosaccharides are also fucosylated as well as
sialylated. It is noteworthy that no GalNAc residues were
observed by GC-MS analysis, which rules out the possibility
of O-linked glycosylation.
The N-linked site occupancy was investigated by peptide
mass fingerprinting following PNGaseF treatment. A PTX3r
sample was reduced and alkylated, then digested with trypsin;
the resulting peptide mixture was analyzed by MALDI-MS
before and after PNGaseF hydrolysis. The mass signal at
m/z 1771.94 was assigned to peptide 215-230 containing
the unique N-glycosylation site and could only be detected
following deglycosylation of the sample. The measured
monoisotopic mass value increased by 1 Da compared to
that expected (1770.96 Da) because Asn220 was converted
into Asp by the enzymatic treatment, thus demonstrating the
complete glycan occupancy at Asn220 (Figure 2B).
FIGURE 4: SDS-PAGE analysis, C1q binding, and SEC profile of asialo and endo F3-PTX3r. (A) Left panel: PTX3r was incubated with
R-(2f3,6,8,9)-neuraminidase under nondenaturing conditions. The extent of sialic acid removal was assessed in SDS-PAGE in comparison
to the same reaction performed under denaturing conditions (asialo-dPTX3r). Middle panel: asialo-PTX3r and PTX3r were serially diluted
to a concentration ranging from 5000 to 10 ng/mL and then added to C1q-coated wells. Data shown are representative of at least three
independent experiments. Right panel: elution profiles of asialo-PTX3r and PTX3r in size exclusion chromatography. Arrows indicate
molecular weight standards (ovalbumin, 43 kDa; catalase, 232 kDa; ferritin, 440 kDa; thyroglobulin, 669 kDa; rabbit IgM, 900 kDa). (B)
Left panel: PTX3r was subjected to incubation with endoglycosidase F3 under nondenaturing conditions. Endo F3-PTX3r was analyzed in
SDS-PAGE and compared to the protein deglycosylated with PNGase F under denaturing conditions (PNGase F). C1q binding assay
(middle panel) and SEC analysis (right panel) were performed as described above for asialo-PTX3r.
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The oligosaccharide chains released from PTX3r by
PNGaseF digestion were recovered and directly analyzed by
MALDI-MS, both in positive and negative ion mode. Sugar
profiling by positive MALDI-MS analysis revealed the
occurrence of fucosylated and variably sialylated or not
sialylated biantennary with minor triantennary structures, thus
confirming that PTX3r oligosaccharides belong to the
complex type (Figure 3A). However, because significant
desialylation has been described to occur in positive ion mode
(38), negative MALDI-MS analyses were also performed.
Because the mass signals corresponding to nonsialylated
biantennary structures disappeared in the acquired negative
ion spectrum (Figure 3B), sialic acid residues were lost to a
great extent in positive ion mode. The intensity ratios among
the observed sialylated structures appeared to be essentially
similar to those recorded in the positive MALDI spectra,
confirming the sugar profiling described therein. To increase
sensitivity of the mass spectral analysis, PTX3r oligosac-
charides were finally examined following peracetylation,
showing the presence of very minor tetrantennary structures
with a different degree of sialylation (data not shown).
The ultimate definition of the different glycan structures
including the sequence and branching degree of the antennae
was achieved by tandem mass spectrometry analysis using
MALDI-PSD techniques. The PSD spectra were dominated
by Y and B ions containing the nonreducing or reducing
ends of the glycans as well as a large number of internal
fragment ions formed by multiple glycosidic cleavages.
Sequence and branching information could be inferred by
the interpretation of the fragmentation spectra. For example,
Figure 3C shows the PSD spectrum obtained by selecting
the precursor ion observed at m/z 1808.64 in the positive
ion spectrum. The B5 ion at m/z 1442.39 resulting from the
cleavage of the glycosidic bond between the two GlcNAc
FIGURE 5: C1q inhibition assays and BIAcore analyses. (A)
Preincubated mixtures of fixed amounts of C1q and serial dilutions
of asialo-PTX3r or PTX3r were added to PTX3r-coated wells. Bound
C1q was revealed, and the results were expressed as both inhibition
percentages (curves) and IC50 values (histogram in the insert). Data
shown are representative of three independent experiments. (B) The
wells were coated with asialo-PTX3r, and inhibition experiments
were performed as in A. (C) BIAcore saturation analysis of PTX3r,
asialo-PTX3r and endo F3-PTX3r binding to C1q. Increasing
concentrations of PTX3 (from 20 to 200 nM) were allowed to
interact with immobilized C1q (base value 18 890 RU) for 4 min,
and association curves were recorded. Buffer was then run over
and dissociation allowed to proceed. The kinetic parameters were
calculated for each sensorgram; corresponding mean values ((stan-
dard error) are indicated in the text. Data are from a single
experiment, representative of four performed.
FIGURE 6: Complement activation on PTX3r and asialo-PTX3r. (A
and B) Wells were coated with PTX3r, asialo-PTX3r, IgM, or
coating buffer (blank), followed by incubation with NHS and
assessment of deposition of C4 (A) and C3 (B). (C) The plates
were coated with PTX3r, asialo-PTX3r or IgM and incubated with
NHS in GVB+/+, GVB+/-/MgEGTA, GVB-/-/EDTA, or with NHS
in the presence of mAb85, and the deposition of C3 was assessed.
(D) PTX3r or asialo-PTX3r was preincubated with purified C1q
and tested in a C1q-dependent haemolytic assay. Data shown in
A, B, and C are representative of three independent experiments;
panel D shows the results from a single experiment, representative
of three performed.
FIGURE 7: SDS-PAGE analysis and C1q binding of endo and
exoglycosidase-treated PTX3 from natural sources. (A) PTX3 from
fibrosarcoma 8387 (8387) and monocyte-derived dendritic cells
(DC) was incubated with endoglycosidase F1 (F1), endoglycosidase
F2 (F2), or endoglycosidase F3 (F3) under nondenaturing condi-
tions. Digestions were carried out on the recombinant protein (CHO)
as well. Reaction products were analyzed on a 8.5% SDS poly-
acrylamide gel, and the electrophoretic mobility was compared to
that of the untreated proteins (C). (B) Proteins were incubated with
R-(2f3,6,8,9)-neuraminidase (Neu), â-(1f4)-galactosidase (â-Gal),
and â-N-acetylglucosaminidase (Glu) under denaturing conditions.
The extent of deglycosylation was monitored in comparison to that
of the untreated proteins (C), as in A. (C) Asialo-PTX38387 and
PTX38387 were serially diluted to a concentration ranging from 1000
to 32 ng/mL and then added to C1q-coated wells. Bound proteins
were revealed by RPTX3pb polyclonal antibody. Reported values
are representative of three independent experiments. (D) Asialo-
PTX3DC and PTX3DC were assayed as in C. Concentration values
ranged from 100 to 3 ng/mL.
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core residues led to the localization of the Fuc moiety on
the first GlcNAc. On the whole, PSD data on the species at
m/z 1808.64 identified a biantennary structure with a Fuc
unit on the first GlcNAc core residue.
PTX3r Glycosylation Status Affects C1q Recognition. The
site of sugar attachment in PTX3 (Asn 220) is located on
the pentraxin domain. Previous results indicate that this
region of the protein is required for C1q recognition (8). To
investigate the role of glycosylation on PTX3 biological
activity, the interaction of PTX3 with C1q was studied.
PTX3r was desialylated with R-(2f3,6,8,9)-neuraminidase
under nondenaturing conditions. As shown in Figure 4A left
panel, NeuNAc residues were extensively removed from
PTX3r in both native and denaturing conditions. Deglyco-
sylated PTX3r was produced by endoglycosidase F3 treat-
ment (Figure 4B, left panel). Asialo-PTX3r and endo F3-
PTX3r were then compared to the untreated protein for their
C1q binding activity. In direct binding experiments, both the
asialo-PTX3r and the endo F3-PTX3r bound immobilized
C1q 2-3 times more than the unmodified PTX3r (Figs 4A
and B, middle panels). Protein concentration was normalized
by Lowry. PTX3r samples were also subjected to ELISA
titration, and concentration values were found identical to
those obtained by Lowry, ruling out the fact that the observed
increase in C1q binding might be ascribed to an increased
affinity of the detection antibody for both asialo-PTX3r and
endo-F3-PTX3r (data not shown).
PTX3 is a decameric protein stabilized by interprotomer
disulfide bonds with a presumably high hydrodynamic
volume and the potential to form supra-aggregates (1).
Consistent with these features, PTX3r was eluted in size
exclusion chromatography (SEC) as a protein with an
estimated molecular weight of 900 kDa (Figs 4A and 4B,
right panels). To assess whether R-(2f3,6,8,9)-neuramini-
FIGURE 8: Representative conformations of a sialylated and
desialylated biantennary oligosaccharide linked to the Asn220 of a
3D model of the PTX3 C-terminus domain. (A) Scheme of a core-
monofucosylated and disialylated biantennary oligosaccharide. (B)
Representative solutions of the sialylated oligosaccharide are
reported in three different colors (orange, green, and purple). The
structural model of the C-terminus domain of PTX3, built by a
homology modeling procedure, is represented as a ribbon colored
by secondary structure. Amino acid residues (ball-and-stick)
contacting sialic acid are accordingly colored. (C) representative
solutions of the desialylated oligosaccharide.
Table 1: Endo and Exoglycosidases Used in PTX3 Glycan
Analysis.
enzyme EC source substrate
PNGase F 3.5.1.52 Chryseobacterium
meningoseptum
All N-linked complex,
hybrid, or high mannose
oligosaccharides unless
â-(1f3)-fucosylateda
endoglycosidase
F1
3.2.1.96 Chryseobacterium
meningoseptum
N-linked high mannose
and hybrid
oligosaccharidesb
endoglycosidase
F2
3.2.1.96 Chryseobacterium
meningoseptum
N-linked high mannose
and biantennary complex
oligosaccharidesb
endoglycosidase
F3
3.2.1.96 Chryseobacterium
meningoseptum
N-linked biantennary
and triantennary complex
oligosaccharidesb
R-(2f3,6,8,9)-
neuraminidase
3.2.1.18 Arthrobacter
ureafaciens
terminal nonreducing
R-(2f3), R-(2f6),
R-(2f8), and
R-(2f9)-linked
NeuNAc residues
â-(1f4)-
galactosidase
3.2.1.23 Streptococcus
pneumoniae
terminal nonreducing
â-(1f4)-linked
Gal residues
â-N-acetylglucos-
aminidase
3.2.1.52 Streptococcus
pneumoniae
terminal nonreducing
â-(1f2) and
â-(1f4)-linked
GlcNAc residues.
a PNGase F cleaves the N-glycosidic bond between the asparagine
and the first GlcNAc residue in the diacetylchitobiose core. The enzyme
works as an amidase with the asparagine being converted to aspartic
acid. b Endoglycosidases F1, F2, and F3 cleave the O-glycosidic bond
between the two GlcNAc residues in the diacetylchitobiose core,
generating a truncated sugar molecule with one GlcNAc remaining on
the peptide moiety.
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dase or endoglycosidase F3 treatments might alter PTX3r
oligomeric organization, we analyzed the elution profile of
the protein in SEC. Both asialo-PTX3r and endo F3-PTX3r
were eluted as a single peak with same retention time and
apparent molecular weight (900 kDa) as those of the native
protein, indicating that no major modification in PTX3r
quaternary structure occurred after NeuNAc removal or
deglycosylation (Figs 4A and B, right panels).
Asialo-PTX3r and endo F3-PTX3r binding to C1q was also
analyzed in competition experiments. Microtiter plate wells
were coated with PTX3r, and the inhibition of C1q binding
to the immobilized protein by asialo-PTX3r was measured.
The results, expressed as both inhibition curves and IC50
values, showed that asialo-PTX3r inhibited the binding of
C1q to immobilized PTX3r at one-third the concentration
required for the untreated protein (3.1 ( 0.2 íg/mL for
asialo-PTX3r compared to 11.6 ( 2.5 íg/mL for PTX3r, in
Figure 5A), which is consistent with the direct binding
experiments described above. Analogous results were achieved
by measuring the inhibition of C1q binding to asialo-PTX3r-
coated wells (2.9 ( 0.4 íg/mL for asialo-PTX3r compared
to 8.9 ( 0.5 íg/mL for PTX3r, in Figure 5B). Endo F3-
PTX3r samples were assayed in the same experimental setting
with comparable results (data not shown).
To further characterize the role of glycosylation on PTX3/
C1q interaction, we investigated the binding to C1q of asialo-
PTX3r and endo F3-PTX3r by means of real-time biomo-
lecular interaction analysis with BIAcore. As shown in Figure
5C upper panel, when C1q was immobilized on the sensor
chip, significant binding of PTX3r was observed. Kinetic
analysis of the interaction between the two molecules allowed
the calculation of a Kon value of 1.98 (( 0.03)  104 M-1
s-1 and a Koff value of 9.39 (( 0.09)  10-4 s-1 (considering
a simple 1:1 interaction and PTX3 as a protomer). Under
the same conditions, sensorgrams relative to asialo-PTX3r
and endo F3-PTX3r exhibited higher RU signals (Figure 5C,
middle and bottom panels, respectively); the corresponding
calculated kinetic constants are Kon ) 2.05 (( 0.03)  104
M-1s-1 and Koff ) 7.62 (( 0.10)  10-4 s-1 for asialo-PTX3r
and Kon ) 1.94 (( 0.02)  104 M-1s-1 and Koff ) 5.80 ((
0.15)  10-4 s-1 for endo F3-PTX3r. Although differences
among the measured parameters were relatively small, they
were reproduced in a set of four independent experiments.
Despite the Kon invariancy among analyzed samples, we
consistently observed a decrease of Koff values as terminal
NeuNAc residues or overall glycosidic moiety were removed
from the protein. This behavior was in agreement with the
binding experiments carried out at equilibrium, further
indicating that deglycosylation stabilizes the PTX3/C1q
complex, reducing its dissociation rate rather than accelerat-
ing molecules association.
PTX3r Sialic Acid Content Affects Complement ActiVation.
We observed that both desialylation and deglycosylation
equally enhanced PTX3r binding to C1q. As sialic acid has
been described to play a key role in modulating glycoproteins
activities (39), we analyzed the effect of desialylation on
PTX3 complement activation.
PTX3r and asialo-PTX3r were immobilized on microtiter
plates, and following incubation with normal human serum
(NHS), activation of C4 and C3 was measured by ELISA.
As shown in Figure 6A and B, the removal of sialic acid
consistently induced an increase in both C4 and C3 deposi-
tion on asialo-PTX3r compared to that on PTX3r with
increased C1q binding, as previously described. As a positive
control of classical complement pathway (CCP) activation,
immobilized IgMs were used. Analogous results were
obtained with F3-PTX3 (data not shown).
With the aim of verifying whether sialylation status could
affect the pathway through which PTX3 activates the
complement system, C3 deposition on PTX3r and asialo-
PTX3r was measured in the presence of the CCP inhibitors
Mg-EDTA and EDTA or the C1q-inhibitory mAb85. Only
the alternative complement pathway, that is neither the CCP
nor the lectin pathways, can proceed in the absence of Ca2+.
No activation of C3 could be observed when Mg-EDTA or
EDTA was added to the complement source, neither on
PTX3r and asialo-PTX3r nor on IgM (Figure 6C). Further-
more, C3 deposition was totally abolished when the activa-
tion assay was performed in the presence of mAb85 (Figure
6C), thus indicating that sialic acid removal from PTX3
cannot shift the pentraxin-dependent complement activation
toward pathways other than the classical one. In C1q-
dependent haemolytic assays, fluid-phase PTX3 competes
with C1q interaction to antibody-sensitized erythrocytes, thus
inhibiting the complement classical pathway as revealed by
a reduction of complement haemolytic activity (8). Asialo-
PTX3r inhibited complement haemolytic activity at about half
the concentration required for the unmodified protein (Figure
6D), indicating that the enhancement in C1q binding and
complemnt activation observed upon the removal of sialic
acid residues is maintained when the protein is in fluid-phase.
In an effort to assess the functional relevance of the
enhanced complement activation by the deglycosylated
PTX3, an air pouch model was used (40) where leukocytes
recruitment is dependent on complement activation (Gar-
landa, unpublished data). In one experiment, the average
number of recruited leukocytes in PTX3 mice was 51 ( 6
(n ) 3), whereas the average number of recruited leukocytes
in F3-PTX3 treated mice was 247 ( 62 (n ) 4) (p <0.01).
Oligosaccharides Structure of PTX3 from Different Cel-
lular Sources. We extended our investigation into the PTX3
oligosaccharide structure to the naturally occurring protein.
Endoglycosidases and exoglycosidases proved effective at
assessing the PTX3r sugar type, as confirmed by mass
spectrometry analysis. Thus, we exploited the analytical
capacity of these enzymes to partially resolve the glycosyl-
ation of PTX3 purified from dendritic and 8387 cells
stimulated with LPS and TNFR, respectively. The natural
protein from both cell types was resistant to endoglycosidase
F1, whereas endoglycosidases F2 and F3 proved effective
in reducing PTX3’s apparent molecular weight (Figure 7A).
These data showed that the natural protein is conjugated to
complex-type sugars, analogous to PTX3r. Interestingly, the
susceptibility of natural PTX3 to endoglycosidase digestion
appeared to be variable. In particular, a higher amount of
PTX3DC retained glycosylation after endoglycosidase F2
hydrolysis with respect to PTX38387 or PTX3r, suggesting
that biantennary structures are a minor fraction of PTX3DC
oligosaccharides. Moreover, the persistence of a large
quantity of glycosylated PTX3DC after endoglycosidase F3
treatment indicates the presence of a higher proportion of
tetrantennary structures (Figure 7A).
The susceptibility of PTX3 from either 8387 or dendritic
cells to sequential monosaccharide hydrolysis by substrate-
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specific exoglycosidases (Figure 7B) confirmed that the
naturally occurring protein carries complex-type sugars, as
does the recombinant one, and revealed the NeuNAc residues
at the nonreducing terminal end of their antennae.
To evaluate the contribution of NeuNAc residues to C1q
interaction, PTX38387 and PTX3DC samples were desialylated
under nondenaturing conditions. Asialo-PTX38387 and asialo-
PTX3DC were then assayed for their binding to C1q. Both
desialylated PTX38387 and PTX3DC showed at least a 2-fold
increase in C1q binding activity compared to that of the
respective unmodified proteins (Figure 7C and D). These
results match those obtained with PTX3r and allow us to
conclude that sialic acid content affects PTX3/C1q interac-
tion. It is noteworthy that unmodified PTX3 from the three
different sources showed variable C1q binding (data not
shown). Such a difference may be ascribed to the variations
observed in the glycosylation status of the examined proteins
(Figure 7A). Although we cannot rule out other possibilities,
those shall be addressed in subsequent investigations.
Conformational Analysis of PTX3 Oligosaccharides. We
evaluated the probability of contacts between biantennary
oligosaccharides and the surface of the PTX3 C-terminus
domain. A core-monofucosylated and disialylated bianten-
nary oligosaccharide (Figure 8A), as the most abundant
PTX3r glycan structure described above, was chosen for the
analysis. The oligossaccharide chain was linked to Asn220
on a 3D model of the PTX3 C-terminus domain elaborated
by homology modeling on the crystallographic structure of
CRP (35). The sugar was then subjected to conformational
analysis using dihedral angle driving and MC/SD procedures
to guarantee an effective local sampling. Thirty three of the
400 oligosaccharide conformations collected showed the
oligosaccharide chain contacting protein surface principally
by the R-(1f6) antenna. In 96% of these solutions, sialic
acid established hydrogen bonds with polar amino acids, and
in the remaining 4%, it was involved in salt bridges with
basic amino acids. Cluster analysis of the sialylated oli-
gosaccharide conformations returned the three representative
solutions shown in Figure 8B, where sialic acid interacts to
Lys214, Glu252, Lys255, and Arg332. The removal of sialic
acid from the terminal end of the disialylated biantennary
oligosaccharide reduced the conformations interacting with
exposed amino acids on protein surface to 14%. Monosac-
charides of the mannosyl-chitobiose core are mainly involved
in these contacts, whereas the antennae extend away from
the protein surface. Representative solutions of the desialyl-
ated oligosaccharide are shown in Figure 8C. The proposed
models in figures 8B and C suggest that sialic acid might
exert a key role in modulating the anchoring of the PTX3
glycosidic moiety to the protein surface.
DISCUSSION
We showed that oligosaccharides conjugated to the
recombinant PTX3 were complex-type sugars, mainly con-
sisting of biantennary fucosylated and variably sialylated
structures. Our mass spectrometry data indicated that the
unique glycosylation site at Asn220 is fully occupied in the
native protein and ruled out the occurrence of O-linked
oligosaccharides, confirming what was suggested in previous
articles (1).
Recombinant PTX3 as well as PTX3 from fibrosarcoma
cell line 8387 and from DC was similarly sensitive to exo
and endoglycosidases digestion, thus indicating that the
naturally occurring PTX3 also exhibits N-linked sialylated
complex-type sugars. We observed intrinsic heterogeneity
in the relative amount of bi, tri, and tetrantennary structures
among the different species of PTX3 as indicated by the
peculiar susceptibility of each species to endoglycosidase
hydrolysis (Figure 7A). This result suggests that changes in
the PTX3 glycosylation pattern might be ascribed to cell type
and inflammatory stimulus.
The site of sugar attachment to PTX3 is located on Asn220
within the pentraxin domain that is known to mediate C1q
recognition (8). We showed that enzymatically deglycosyl-
ated or desialylated PTX3 bound C1q 2-3-fold more than
the unmodified protein, and we confirmed the specificity of
this effect by competition experiments. The observed C1q
binding enhancement did not appear to be determined by
major rearrangements in the protein oligomeric status as
potentially induced by sugars hydrolysis. SEC profiles of
both deglycosylated and desialylated PTX3 matched that of
the unmodified protein, indeed, retaining the apparent
molecular weight of 900 kDa. However, we cannot rule out
the possibility that changes in glycan composition may
induce subtle modifications in PTX3 quaternary structure not
detectable by SEC analysis.
We built a 3D model of the glycosylated PTX3 C-
terminus, highlighting that oligosaccharides locally contact
the PTX3 surface. Noteworthy sialic acid residues interact
with polar and basic amino acids (Lys214, Glu252, Lys255,
Arg332) at sites far from Asn220, carrying N-glycosylation.
The removal of sialic acid from the nonreducing end of
biantennary oligosaccharides induced glycan conformational
changes that released their antennae away from the protein
surface. We reported that either deglycosylation or desialyl-
ation equally enhanced PTX3 binding to C1q, indicating
sialic acid as the main determinant of this effect. Our model
proposes that the removal of sialic acid might determine new
orientations of PTX3 oligosaccharides and analogous to
deglycosylation, expose amino acids potentially relevant
either to C1q recognition or to rearrangements of protein
tertiary and quaternary structure.
The C1q binding enhancement observed for the recom-
binant protein upon removal of sialic acid was reproduced
with the naturally occurring species (PTX38387 and PTX3DC),
thus indicating that desialylation also determines similar
effects on the endogenous protein.
Because sialic acid plays a key role in modulating
glycoprotein activity (39), we analyzed the effect of desia-
lylation on PTX3 complement activation. It is known that
PTX3 can both activate and inhibit the complement classical
pathway depending on the way the protein is presented.
Immobilized PTX3 induces complement activation as as-
sessed by C3 and C4 deposition experiments, whereas the
interaction of PTX3 with C1q in fluid phase inhibits
complement cascade as established by the reduction of
complement haemolytic activity (8). We observed a 2-fold
increase in C3 and C4 deposition with desialylated PTX3
compared to that of the unmodified protein. This enhance-
ment in complement activation indeed depends on PTX3/
C1q interaction because it was blocked by inhibitories of
the classical pathway. The effect of desialylation on PTX3
complement activation was also assessed in a C1q-dependent
haemolytic assay. Consistently with the C1q binding experi-
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ments, desialylated PTX3 inhibited complement cascade at
about half the concentration required for the unmodified
protein. These results suggest that the strengthened interaction
with C1q observed upon removal of sialic acid is independent
of the way the protein is presented, either immobilized or in
fluid-phase. Furthermore, desialylation of PTX3 enhances
both the activatory and inhibitory function of the protein on
complement cascade.
Some explanations of the mechanism through which PTX3
glycosylation affects C1q binding were provided by kinetic
analyses performed with the BIAcore system. Stoichiometry
of the PTX3/C1q complex has not been defined yet, likely
due to the complexity of interaction (8). BIAcore raw data
were thus analyzed under the simple hypotheses of 1:1
interaction and PTX3 as a protomer. The observed differ-
ences among PTX3 glycosylation variants indicated that C1q
binding strengthening produced by sugar removal was due
to a decrease in the Koff values. This result allowed us to
conclude that deglycosylation stabilizes the PTX3/C1q
complex, reducing the rate of its dissociation rather than
increasing molecular association.
Complement activation is an enzymatic process that might
be associated with amplification of interactions occurring
early in the cascade. An example of this is provided by the
mutagenesis study performed on CRP where a 2-3-fold
enhancement in C1q binding, exhibited by some of the
mutants, led to a 10 fold amplification in C3 deposition
experiments (41). We observed a 2-3-fold enhancement in
complement activation that reflects the stabilization of the
asialo-PTX3/C1q complex and suggests that the nature of
the interaction between asialo-PTX3 and C1q does not affect
the serine protease activity of C1s and C1r. However, the
increase described in complement activation is susceptible
to induce more pronounced effects downstream in the
inflammatory cascade. Consistent with this view, F3-PTX3
induces about a 5-fold enhancement of leucocytes recruitment
than the unmodified protein in the air-pouch model (40),
thus further indicating that the stabilization of the interaction
of deglycosylated PTX3 with C1q is functionally relevant.
Protein-conjugated oligosaccharides can be processed in
the extracellular environment by specific exoglycosidases;
among these, neuraminidases appear to be particularly
relevant because of their biological roles (42). Infact, several
studies showed that different pathogens express neuramini-
dases on their surface during infection (43, 44) and that
natural immunity cells, such as polymorphonuclear leuco-
cytes, also mobilize intracellular neuraminidases to the
plasma membrane upon inflammatory stimuli (45). Here, we
provide evidences that the PTX3 glycosylation status affects
the interaction with C1q, and in this way, it is capable of
modulating the activation of complement classic pathway.
PTX3 has been functionally defined as a soluble pattern
recognition receptor (SPRR) because it binds selected
pathogens. The interaction of PTX3 with pathogens has the
potential to promote complement opsonization, mediating
microbicidal activity (6). Our study indicates that glycosyl-
ation might represent a strategy to tune PTX3 activity and
paves the way for a new series of investigations aimed at
establishing the biological relevance of PTX3 glycosylation
in vivo.
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